Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2016 - 2025)

Ani Pharmaceuticals' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.62 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 29.82% year-over-year to 0.62; the TTM value through Dec 2025 reached 0.62, up 29.82%, while the annual FY2025 figure was 0.65, 15.5% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.62 at Ani Pharmaceuticals, up from 0.6 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.62 in Q4 2025 and bottomed at 0.28 in Q4 2021.
  • The 5-year median for Asset Utilization Ratio is 0.49 (2023), against an average of 0.46.
  • The largest annual shift saw Asset Utilization Ratio crashed 38.35% in 2021 before it surged 57.73% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.28 in 2021, then surged by 51.68% to 0.42 in 2022, then increased by 28.56% to 0.54 in 2023, then fell by 11.95% to 0.48 in 2024, then rose by 29.82% to 0.62 in 2025.
  • Per Business Quant, the three most recent readings for ANIP's Asset Utilization Ratio are 0.62 (Q4 2025), 0.6 (Q3 2025), and 0.57 (Q2 2025).